The nanomaterials industry has a wide range of applications, including in electronics, where they are used to enhance the performance and miniaturization of components, and in medicine, where they contribute to advanced drug delivery systems and diagnostics. Additionally, they are employed in landscapes such as energy, for improving efficiency in solar cells and batteries, and in environmental applications, for water purification and pollution control.  

 

Allied Market Research recently published a report on the industry prospects of nanomaterials. In 2021, the global nanomaterials market was valued at $16.3 billion and is expected to expand to $62.8 billion by 2031, reflecting a CAGR of 14.6% from 2022 to 2031. 

 

The global nanomaterials industry is fueled by several factors, comprising of technological advancements that enhance the performance and range of applications, such as in electronics, healthcare, and energy sectors. Rising demand for nanomaterials in medical applications, like drug delivery and diagnostics, also fuels market growth. Furthermore, the need for energy-efficient technologies, along with advanced batteries and solar cells, supports the industry's expansion. hurdles and market uncertainties, create significant obstacles that impact the landscape's development and adoption rates. 

 

Key benefits for stakeholders 

This report offers a thorough examination of various market segments, delivering detailed estimates for the nanomaterials industry from 2022 to 2031. It provides insights into the market size in terms of both revenue and volume. and forecasts future developments, helping stakeholders identify existing market opportunities and plans accordingly. 

 

Key players mentioned in the study 

  • Merck KGaA 

  • NanoCyl SA 

  • Arkema Group 

  • Daikin Industries Ltd. 

  • UMICORE NV 

  • Evonik Industries AG 

  • DuPont 

  • LG Chem 

  • Lanxess Corporation 

  • Nanoco Technologies Limited